CBD and GABA: a natural synergy for relaxation and wellbeing

In the search for natural ways to improve mental wellbeing and reduce anxiety, CBD and GABA have emerged as two key components. Although they differ in origin and function, combining them can offer benefits in promoting relaxation and calm. In today’s Cannactiva post, we explain what GABA is, what it does, and how cannabis and CBD affect the levels of this neurotransmitter, which is so important for relaxation and neuronal balance in our body.
What is GABA?
GABA (gamma-aminobutyric acid) is the brain’s main inhibitory neurotransmitter, responsible for promoting relaxation. This neurotransmitter plays a crucial role in regulating the activity of neurons and maintaining a proper balance between excitation and calm in our brain (1).

GABA helps relax the nervous system by acting as a brake on the brain, reducing the activity or excitation of neurons. It works together with glutamate, which does the opposite and increases the excitation of neurons. The brain works best when there is a proper balance between excitation (glutamate) and neuronal inhibition (GABA).
Emotions and sensations produced by GABA
GABA is known for its calming effects on the brain and body, helping to reduce stress and anxiety (3). However, more research is still needed to fully understand these effects.
Neurons communicate through electrical signals called action potentials. These signals cause neurons to release neurotransmitters, which then activate other neurons. The action potential is the fundamental basis of neuronal communication, and GABA has the ability to stop this communication from continuing, thus reducing the excitation of neurons.
In fact, some antidepressant and anti-anxiety medications act on GABA, enhancing its action to relieve symptoms of depression and anxiety. Examples of these medications include benzodiazepines, such as diazepam (Valium) and alprazolam (Xanax), and certain anticonvulsants, such as valproic acid (Depakote) and gabapentin (Neurontin). Alcohol, for example, enhances GABA and therefore has a sedative effect. However, withdrawal rapidly reduces GABA, resulting in symptoms of hyperexcitability such as anxiety, tremors and even seizures.

What CBD is and how it relates to GABA
CBD (cannabidiol) is a natural compound derived from the cannabis plant, with no psychoactive effects and with proven benefits for anxiety and pain, among other conditions. Both CBD and other cannabinoids can interact with several neurotransmitter systems, including GABA and GABAergic neurotransmission.
Effects of CBD on GABA
CBD, known for its calming and anxiolytic effects, can influence GABA levels in the brain and GABA activity.
CBD can make more GABA available in the brain by preventing it from being broken down or reabsorbed (reuptake). In addition, CBD binds to specific receptors called GABA A, improving their efficacy. All of this means that GABA can do a better job of calming the brain. In this way, cannabidiol could lead to a more effective reduction in anxiety and a general state of relaxation.
Details: how CBD and GABA interact
CBD has been shown to bind to GABA A receptors, increasing their efficacy and enhancing the inhibitory effects of GABA (10, 11). This modulation of GABA by CBD may contribute to CBD’s anxiolytic and anticonvulsant properties.
On the other hand, CBD can inhibit the reuptake of a compound called adenosine, which could result in the modulation of GABA and glutamate release, affecting the overall excitatory/inhibitory balance in the CNS (12).

Potential therapeutic benefits of CBD + GABA
The effect of CBD on GABA has given cannabidiol notable therapeutic uses in the treatment of anxiety and depression. CBD’s anxiolytic effects are mediated by GABAergic modulation, although CBD is anxiolytic for many other reasons too, such as its influence on the anandamide or serotonin cycle. The lack of significant side effects and its low potential for dependence make CBD an attractive option for long-term use.
The anticonvulsant properties of CBD have led to its approval for specific types of epilepsy. By enhancing GABAergic neurotransmission, CBD reduces the frequency and severity of seizures, offering a new avenue for patients who do not respond to traditional antiepileptic drugs.
Effects of THC on GABA
THC, the main cannabinoid in psychoactive, drug-type cannabis, interacts mainly with the cannabinoid receptors CB1 and CB2 of the human body’s endocannabinoid system. Neurons that use GABA also have these CB1 receptors, which makes them sensitive to the effects of THC.
When THC binds to CB1 receptors on GABAergic neurons, it can reduce the release of GABA. Less GABA means there are fewer “brakes” on excitatory neuronal activity, which can increase signal transmission in the brain. This increased excitatory activity contributes to the psychoactive effects of THC, such as altered perception, mood changes and a feeling of euphoria. In other words, THC has a different effect on the brain from CBD.
Details: effects of THC on GABA
GABAergic neurons have CB1 receptors, so activation of these receptors by THC can reduce GABA release (9). As less GABA is released, inhibition of excitatory neurotransmission decreases. This may result in increased transmission of excitatory signals, contributing to some of the psychoactive effects of THC, such as altered perception, mood changes and euphoria.
Conclusion
GABA is a neurotransmitter that helps calm brain activity. CBD can increase GABA levels in the brain, which helps reduce anxiety and improve wellbeing. However, the details of how CBD achieves this are not yet fully understood and require further research. THC, on the other hand, acts in the opposite way to CBD: it reduces GABA levels and increases neuronal excitability, which can lead to psychoactive effects such as euphoria and mood changes.
Note: This is an informational article based on the latest scientific research. It is not intended to prevent, diagnose or treat any disease. Its content may complement, but should never replace, any diagnosis or treatment of any disease or symptom. Cannactiva products are not medicines and are intended for external use. The authors and Cannactiva are not responsible for any misuse of this information. Please bear in mind that new scientific evidence may have emerged since the date of publication. For all these reasons, consult your doctor before using CBD or if you have any questions about it.
Frequently asked questions
What effects does GABA produce?
GABA reduces neuronal activity and prevents hyperactivity in the brain.
It promotes relaxation and reduces stress responses, acting as a natural anxiolytic. It also supports sleep and relaxation, working as a sedative, and helps to reduce muscle tension, acting as a muscle relaxant.
How do we get GABA?
GABA is produced naturally in the brain from the amino acid glutamate (another neurotransmitter), with the help of vitamin B6. GABA can also be obtained from certain foods that are naturally rich in this neurotransmitter.
Which foods are rich in GABA?
GABA can be found naturally in some foods. These include dairy products, especially fermented ones (yoghurt, kefir), fish, nuts and seeds (cocoa or dark chocolate, almonds, walnuts, sunflower seeds), legumes (tofu, tempeh, lentils), edible mushrooms, oats, spinach, tomatoes, broccoli and potatoes. In some countries there are already GABA-enriched products, and GABA supplements are also sold.
Can a diet rich in GABA increase its levels?
Yes, although the amount that actually reaches the brain, and its effect, may vary from person to person. Some research groups have found that a diet of GABA-rich foods could be beneficial in helping to treat anxiety and depression (8). Lifestyle also influences GABA levels.
What happens when there is a lack of GABA?
Low levels of GABA have been found to be potentially responsible for depression, mood changes, insomnia, anxiety, panic attacks and certain types of epilepsy (4, 5, 6, 7).
References
- Paz, Lenin & Gulias-Cañizo, Rosario & Ruíz-Leyja, Estela & Sánchez-Castillo, Hugo & Parodi, Jorge. (2021). The role of GABA neurotransmitter in the human central nervous system, physiology, and pathophysiology. Revista Mexicana de Neurociencia. 22. https://doi.org/10.24875/RMN.20000050
- Soghomonian, J. J., & Martin, D. L. (1998). Two isoforms of glutamate decarboxylase: why?. Trends in pharmacological sciences, 19(12), 500–505. https://doi.org/10.1016/s0165-6147(98)01270-x
- Hepsomali, P., Groeger, J. A., Nishihira, J., & Scholey, A. (2020). Effects of Oral Gamma-Aminobutyric Acid (GABA) Administration on Stress and Sleep in Humans: A Systematic Review. Frontiers in neuroscience, 14, 923. https://doi.org/10.3389/fnins.2020.00923
- Wafford, K. A., van Niel, M. B., Ma, Q. P., Horridge, E., Herd, M. B., Peden, D. R., Belelli, D., & Lambert, J. J. (2009). Novel compounds selectively enhance delta subunit containing GABA A receptors and increase tonic currents in thalamus. Neuropharmacology, 56(1), 182–189. https://doi.org/10.1016/j.neuropharm.2008.08.004
- Hasler, G., Nugent, A. C., Carlson, P. J., Carson, R. E., Geraci, M., & Drevets, W. C. (2008). Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography. Archives of general psychiatry, 65(10), 1166–1175. https://doi.org/10.1001/archpsyc.65.10.1166
- Smoller, J. W., Rosenbaum, J. F., Biederman, J., Susswein, L. S., Kennedy, J., Kagan, J., Snidman, N., Laird, N., Tsuang, M. T., Faraone, S. V., Schwarz, A., & Slaugenhaupt, S. A. (2001). Genetic association analysis of behavioral inhibition using candidate loci from mouse models. American journal of medical genetics, 105(3), 226–235. https://doi.org/10.1002/ajmg.1328
- Gold, B. I., Bowers, M. B., Jr, Roth, R. H., & Sweeney, D. W. (1980). GABA levels in CSF of patients with psychiatric disorders. The American journal of psychiatry, 137(3), 362–364. https://doi.org/10.1176/ajp.137.3.362
- Hou, D., Tang, J., Feng, Q., Niu, Z., Shen, Q., Wang, L., & Zhou, S. (2023). Gamma-aminobutyric acid (GABA): a comprehensive review of dietary sources, enrichment technologies, processing effects, health benefits, and its applications. Critical reviews in food science and nutrition, 1–23. Advance online publication. https://doi.org/10.1080/10408398.2023.2204373
- Lupica, C. R., Riegel, A. C., & Hoffman, A. F. (2004). Marijuana and cannabinoid regulation of brain reward circuits. British journal of pharmacology, 143(2), 227–234. https://doi.org/10.1038/sj.bjp.0705931
- Ruffolo, G., Gaeta, A., Cannata, B., Pinzaglia, C., Aronica, E., Morano, A., Cifelli, P., & Palma, E. (2022). GABAergic Neurotransmission in Human Tissues Is Modulated by Cannabidiol. Life (Basel, Switzerland), 12(12), 2042. https://doi.org/10.3390/life12122042
- Bakas, T., van Nieuwenhuijzen, P. S., Devenish, S. O., McGregor, I. S., Arnold, J. C., & Chebib, M. (2017). The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAa receptors. Pharmacological research, 119, 358–370. https://doi.org/10.1016/j.phrs.2017.02.022
- Martinez Naya, N., Kelly, J., Corna, G., Golino, M., Abbate, A., & Toldo, S. (2023). Molecular and Cellular Mechanisms of Action of Cannabidiol. Molecules (Basel, Switzerland), 28(16), 5980. https://doi.org/10.3390/molecules28165980



